Noninvasive evaluation of PD-L1 expression in non-small cell lung cancer by immunoPET imaging using an acylating agent-modified antibody fragment.
Yuan ChengDai ShiRenjie YeWenhui FuPengcheng MaZhan SiZhan XuLixin LiQingyu LinDengfeng ChengPublished in: European journal of nuclear medicine and molecular imaging (2023)
was successfully synthesized through the SHPP modification strategy. The prepared probe was able to accurately evaluate the PD-L1 expression level through high-contrast noninvasive imaging.